France to reform its pharmaceutical regulatory system…with possible global implications!
On 23 June 2011, the French Health Minister proposed significant reforms to the French pharmaceutical regulatory system.
read more…
Way more than an everyday interest in IP
On 23 June 2011, the French Health Minister proposed significant reforms to the French pharmaceutical regulatory system.
read more…
On Monday, the Prime Minister Julia Gillard, and her New Zealand counterpart John Key, announced that both countries had signed a statement of intent to create a joint authority to regulate medicines and medical devices in both countries.
Further to our post on 15 March 2011, the Property Laws Amendment (Raising The Bar) Bill 2011 was introduced to the Senate late last week for consideration and debate. This is the first step in the process of the Bill becoming law. The Bill proposes to make a number of significant amendments to the Patents Act 1990, Trade Marks Act 1995, Designs Act 2003 and Plant Breeders Rights Act 1994, with the amendments intended to encourage innova read more…
Following from our previous post, on 3 June 2011, the Federal Government released its responses to the Advisory Council on Intellectual Property (ACIP) report entitled Post-Grant Patent Enforcement Strategies. In its report, ACIP made a number of recommendations to reduce the e read more…
Further to our previous post, the European Commission has recently launched an official investigation into a settlement agreement made between the US company Cephalon, and the Israeli generic medicine manufacturer, Teva.
read more…
AstraZeneca has been unsuccessful in its attempt to overturn a decision of the Minister for Health and Ageing to include a particular dose of rosuvastatin (sold as Crestor, to lower cholesterol) in the Statins-HP “therapeutic group” on the Pharmaceutical Benefits Scheme (“PBS“). The effect of the Minister’s decision is to reduce the PBS listed price of Crestor (and ultimately, the price which AstraZeneca may charge) on the basis of the listed prices of other drugs such as atorvastatin (Lipitor) within the therapeutic group.
read more…
Last week we challenged our readers to guess the brands in our World IP Day quiz. Take a quick look here if you missed it because we reveal the answers over the fold …
Some of these were harder than others. Congratulations to those of you who picked Ikea – you’ve got a better eye than me!
The answers
Did you know that yesterday was World Intellectual Property Day? Neither did we, until we were alerted to the fact by IP Australia recently. World IP Day is designed to raise awareness of how patents, copyright, trade marks and designs impact our daily lives, something we here at IP Whiteboard whole-heartedly support. read more…
The Federal Government has released exposure drafts of its legislation on a national business names registration system. The proposed new system will give the Australian Securities and Investments Commission (ASIC) national responsibility for registering, renewing and administering business names for all Australian businesses.